Literature DB >> 9649178

Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.

M A Nash1, R Lenzi, C L Edwards, J J Kavanagh, A P Kudelka, C F Verschraegen, C D Platsoucas, R S Freedman.   

Abstract

T cell lines derived in low concentrations of recombinant IL-2 (rIL-2) from TIL of patients with epithelial ovarian carcinoma (EOC) often exhibit specific cytotoxicity against autologous tumour cells. However, the ability of T cells at the tumour site to respond to ovarian carcinoma cells may be affected by the production of cytokines by the various cell types present. Using reverse transcriptase-polymerase chain reaction (RT-PCR) we investigated cytokine transcripts in: (i) established EOC tumour cell lines; (ii) solid tumour specimens or peritoneal exudate cells (PEC) from ascites or peritoneal washings of patients with EOC; and (iii) CD4+ TCRalphabeta+ and CD8+ TCRalphabeta+ TIL-derived T cell lines developed in rIL-2. We have found that (i) established EOC tumour cell lines expressed transcripts for transforming growth factor-beta 2 (TGF-beta2) (7/7), but not IL-10 (0/7) or interferon-gamma (IFN-gamma) (0/7) and rarely IL-2 (1/7); (ii) PEC expressed transcripts for IL-2 (12/13), IL-10 (9/13), and TGF-beta2 (12/13), and less often, IFN-gamma (3/13), whereas solid tumour specimens from eight patients with EOC expressed transcripts for IL-2 (4/8), TGF-beta2 (4/8), and IL-10 (5/8), but not for IFN-gamma (0/8); (iii) CD4+ TCRalphabeta+ T cell lines expressed transcripts for IFN-gamma (4/4), IL-2 (4/4) and IL-10 (3/4), whereas CD8+ TCRalphabeta+ T cell lines expressed transcripts for IFN-gamma (5/5), IL-2 (1/5) and IL-10 (2/5). None of these T cell lines expressed TGF-beta2 transcripts. The frequency of IL-2 and TGF-beta2 transcripts in solid tumours was significantly lower than in the PEC (P = 0.0475). CD4+ or CD8+ T cell lines expressing IFN-gamma, IL-2 and IL-10 transcripts were derived in culture with rIL-2 from the TIL of specimens that did not necessarily express these cytokines in the absence of rIL-2. The frequency of cytokine transcripts in T cell lines compared with these same transcripts in the PEC was significantly higher for IFN-gamma (P = 0.0005) and lower for TGF-beta2 (P = 0.0001). An association was observed between the expression of cytokine transcripts in vivo or by TIL-derived cell lines and functions exhibited by either production of cytokines or in vitro cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649178      PMCID: PMC1904977          DOI: 10.1046/j.1365-2249.1998.00576.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes.

Authors:  M F Romano; A Lamberti; A Petrella; R Bisogni; P F Tassone; S Formisano; S Venuta; M C Turco
Journal:  J Immunol       Date:  1996-03-15       Impact factor: 5.422

2.  Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinoma.

Authors:  R S Freedman; J A Gibbons; M Giedlin; A P Kudelka; J J Kavanagh; C L Edwards; C H Carrasco; M A Nash; C D Platsoucas
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1996-11

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Lineage-negative human leukocyte antigen-DR+ cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis.

Authors:  B Melichar; C Savary; A P Kudelka; C Verschraegen; J J Kavanagh; C L Edwards; C D Platsoucas; R S Freedman
Journal:  Clin Cancer Res       Date:  1998-03       Impact factor: 12.531

5.  HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.

Authors:  S Kooi; H Z Zhang; R Patenia; C L Edwards; C D Platsoucas; R S Freedman
Journal:  Cell Immunol       Date:  1996-12-15       Impact factor: 4.868

6.  Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth.

Authors:  W C Lin; S Yasumura; Y Suminami; M W Sung; S Nagashima; J Stanson; T L Whiteside
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

7.  Interleukin-4 inhibits the expression of tumour necrosis factors alpha and beta, interleukins-1 beta and -6 and interferon-gamma.

Authors:  J D Lee; K Rhoades; J S Economou
Journal:  Immunol Cell Biol       Date:  1995-02       Impact factor: 5.126

8.  Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody.

Authors:  S Canevari; G Stoter; F Arienti; G Bolis; M I Colnaghi; E M Di Re; A M Eggermont; S H Goey; J W Gratama; C H Lamers
Journal:  J Natl Cancer Inst       Date:  1995-10-04       Impact factor: 13.506

9.  Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.

Authors:  W P McGuire; W J Hoskins; M F Brady; P R Kucera; E E Partridge; K Y Look; D L Clarke-Pearson; M Davidson
Journal:  N Engl J Med       Date:  1996-01-04       Impact factor: 91.245

10.  T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-beta 2: modulation by the phosphatase inhibitors okadaic acid and calyculin A.

Authors:  M Weller; U Malipiero; P Groscurth; A Fontana
Journal:  Exp Cell Res       Date:  1995-12       Impact factor: 3.905

View more
  9 in total

Review 1.  Tumor infiltrating lymphocytes in ovarian cancer.

Authors:  Phillip P Santoiemma; Daniel J Powell
Journal:  Cancer Biol Ther       Date:  2015-04-20       Impact factor: 4.742

2.  IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion.

Authors:  Vasilena Gocheva; Hao-Wei Wang; Bedrick B Gadea; Tanaya Shree; Karen E Hunter; Alfred L Garfall; Tara Berman; Johanna A Joyce
Journal:  Genes Dev       Date:  2010-01-15       Impact factor: 11.361

3.  Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer.

Authors:  Chan-Zhen Liu; Li Zhang; Xiao-Hong Chang; Ye-Xia Cheng; Hong-Yan Cheng; Xue Ye; Tian-Yun Fu; Jun Chen; Heng Cui
Journal:  Chin J Cancer Res       Date:  2012-06       Impact factor: 5.087

4.  Ovarian cancer, the coagulation pathway, and inflammation.

Authors:  Xipeng Wang; Ena Wang; John J Kavanagh; Ralph S Freedman
Journal:  J Transl Med       Date:  2005-06-21       Impact factor: 5.531

5.  Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease.

Authors:  Xipeng Wang; Michael Deavers; Rebecca Patenia; Roland L Bassett; Peter Mueller; Qing Ma; Ena Wang; Ralph S Freedman
Journal:  J Transl Med       Date:  2006-07-06       Impact factor: 5.531

Review 6.  The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis.

Authors:  Angela Rynne-Vidal; José Antonio Jiménez-Heffernan; Concepción Fernández-Chacón; Manuel López-Cabrera; Pilar Sandoval
Journal:  Cancers (Basel)       Date:  2015-09-29       Impact factor: 6.639

7.  Clonally expanded alpha-chain T-cell receptor (TCR) transcripts are present in aneurysmal lesions of patients with Abdominal Aortic Aneurysm (AAA).

Authors:  Song Lu; John V White; Raquel I Judy; Lisa L Merritt; Wan Lu Lin; Xiaoying Zhang; Charalambos Solomides; Ifeyinwa Nwaneshiudu; John Gaughan; Dimitri S Monos; Emilia L Oleszak; Chris D Platsoucas
Journal:  PLoS One       Date:  2019-07-16       Impact factor: 3.240

8.  IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer.

Authors:  Kevin M Hart; Katelyn T Byrne; Michael J Molloy; Edward M Usherwood; Brent Berwin
Journal:  Front Immunol       Date:  2011-07-21       Impact factor: 7.561

9.  Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC).

Authors:  Ralph S Freedman; Michael Deavers; Jinsong Liu; Ena Wang
Journal:  J Transl Med       Date:  2004-06-25       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.